概要
The Wolverine Stack combines two of the most well-researched regenerative peptides in the biohacking community: BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 fragment). BPC-157 is a 15-amino-acid synthetic peptide derived from a protective protein found in human gastric juice. It operates through multiple mechanisms including upregulation of growth factor receptors (VEGF, FGF, EGF), modulation of the nitric oxide system, and promotion of angiogenesis — the formation of new blood vessels at injury sites. In animal models, BPC-157 has demonstrated remarkable ability to accelerate healing of tendons, ligaments, muscles, and even bone. TB-500 is the active region of Thymosin Beta-4, a 43-amino-acid protein naturally present in nearly all human cells. It functions primarily by sequestering G-actin, which promotes cellular migration to wound sites, and by upregulating actin polymerization — essential for cellular repair and tissue remodeling. TB-500 also reduces inflammation by decreasing pro-inflammatory cytokines and promotes stem cell maturation and differentiation. The synergy between these two peptides is substantial. BPC-157 creates new vascular pathways to the injury site while TB-500 facilitates cellular migration along those pathways. BPC-157 provides local tissue-specific repair signaling while TB-500 offers systemic anti-inflammatory and repair activation. Together, they cover both the vascular supply and the cellular machinery needed for complete tissue regeneration. This combination is favored by athletes and individuals recovering from soft-tissue injuries, with many reporting noticeable improvement within 1-2 weeks of initiation.
投与プロトコル
250 mcg
1回の投与あたり
2,500 mcg
1回の投与あたり
目標と証拠
警告
- BPC-157 and TB-500 were removed from the FDA Category 2 list (April 2026) but remain under PCAC review (July 23, 2026) — removal is not approval; neither is legal to compound yet.
Comments
Sign in to join the discussion
注意: このスタックはコミュニティから提出され、研究用のみです。Peptide Contactsは提出されたスタックの安全性や効果性を確認していません。使用するペプチドプロトコル前に常に資格のある医療専門家に相談してください。